The proinflammatory capacity of peripheral lymphocytes, mainly their IFN-γ production, was suggested to be a predictive marker for inhibition of tumor progression and preferable survival outcomes following PD-1 or dual PD-1/CTLA-4 blockade [40,41,47]. This evidence concerns the gene CTLA4 and neoplasm.